undamentalytics Newsletter
Sign in

Protagonist Therapeutics, Inc balance sheet

At the end of fiscal 2025, Protagonist Therapeutics, Inc had total assets of $668m, total liabilities of $53.5m and shareholders' equity of $615m. It held $128m in cash against $0 of debt: net cash of $128m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents106823311712412618797128420
Total current assets151138145316341243356592578807
Total assets164139155324348248358745668886
Accounts payable1633241253
Deferred revenue (current)3281814100———
Total current liabilities43263540443121474537
Long-term debt——10———————
Total debt0010—000000
Total liabilities43277545483221695344
Shareholders' equity12111380280300216337675615842
Net debt (negative = net cash)−106−82−23−117−124−126−187−97−128−420
Shares outstanding21m23m27m—48m49m58m61m63m65m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: PHAT vs PTGXPTGX vs SNDXPTGX vs VIR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Protagonist Therapeutics, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Protagonist Therapeutics, Inc.